Aarey Drugs & Pharmaceuticals Quarterly Results for Trading Insights
AAREYDRUGS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹4 Cr
QMarch 2025
Aarey Drugs & Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹484 Cr in March 2025 (+0.0% vs March 2025, +20.1% vs March 2024)
- Net Profit of ₹4 Cr in March 2025 (+0.0% vs March 2025, -20.0% vs March 2024)
- EBITDA of ₹13 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 1.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹1.42 in March 2025 (+0.0% vs March 2025)
Aarey Drugs & Pharmaceuticals Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 405 | 484 | 403 | 422 | 495 | -16.3% | - |
| Net Profit (₹ Cr) | 4 | 4 | 5 | 4 | 7 | - | - |
| EBITDA (₹ Cr) | 13 | 13 | 11 | 11 | 14 | - | - |
| EPS (₹) | 1.20 | 1.42 | 1.84 | 1.49 | 2.72 | - | - |
| Operating Margin (%) | 0.0% | 1.0% | 1.0% | 2.0% | 2.0% | - | - |
Aarey Drugs & Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Aarey Drugs & Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Aarey Drugs & Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Aarey Drugs & Pharmaceuticals
Additional stock information and data for AAREYDRUGS
Revenue Trend (₹ Cr)
March 2023
422
March 2024
403
March 2025
484
2026
405
Net Profit Trend (₹ Cr)
March 2023
4
March 2024
5
March 2025
4
2026
4
Operating Margin Trend (%)
March 2023
2.0%
March 2024
1.0%
March 2025
1.0%
2026
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Aarey Drugs & Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores